Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/126395
Title: | Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study |
Author: | Michaud, Dominique S. Izard, Jacques Wilhelm-Benartzi, Charlotte S. You, Doo-Ho Grote, Verena A. Tjønneland, Anne Dahm, Christina C. Overvad, Kim Jenab, Mazda Fedirko, Veronika Boutron-Ruault, Marie-Christine Clavel-Chapelon, Françoise Racine, Antoine Kaaks, Rudolf Boeing, Heiner Foerster, Jana Trichopoulou, Antonia Lagiou, Pagona Trichopoulos, Dimitrios Sacerdote, Carlotta Sieri, Sabina Palli, Domenico Tumino, Rosario Panico, Salvatore Siersema, Peter D. Peeters, Petra H. M. Lund, Eiliv Barricarte, Aurelio Huerta Castaño, José María Molina Montes, Esther Dorronsoro, Miren Quirós, J. Ramón Duell, Eric J. Ye, Weimin Sund, Malin Lindkvist, Björn Johansen, Dorthe Khaw, Kay-Tee Wareham, Nicholas J. Travis, Ruth C. Vineis, Paolo Bueno de Mesquita, H. Bas Riboli, Elio |
Keywords: | Càncer de pàncrees Malalties periodontals Pancreas cancer Periodontal disease |
Issue Date: | Dec-2013 |
Publisher: | BMJ Publishing Group |
Abstract: | Objective: Examine the relationship between antibodies to 25 oral bacteria and pancreatic cancer risk in a prospective cohort study. Design: We measured antibodies to oral bacteria in prediagnosis blood samples from 405 pancreatic cancer cases and 416 matched controls, nested within the European Prospective Investigation into Cancer and Nutrition study. Analyses were conducted using conditional logistic regression and additionally adjusted for smoking status and body mass index. Results: Individuals with high levels of antibodies against Porphyromonas gingivalis ATTC 53978, a pathogenic periodontal bacteria, had a twofold higher risk of pancreatic cancer than individuals with lower levels of these antibodies (OR 2.14; 95% CI 1.05 to 4.36; >200ng/ml vs 200ng/ml). To explore the association with commensal (non-pathogenic) oral bacteria, we performed a cluster analysis and identified two groups of individuals, based on their antibody profiles. A cluster with overall higher levels of antibodies had a 45% lower risk of pancreatic cancer than a cluster with overall lower levels of antibodies (OR 0.55; 95% CI 0.36 to 0.83). Conclusion: Periodontal disease might increase the risk for pancreatic cancer. Moreover, increased levels of antibodies against specific commensal oral bacteria, which can inhibit growth of pathogenic bacteria, might reduce the risk of pancreatic cancer. Studies are needed to determine whether oral bacteria have direct effects on pancreatic cancer pathogenesis or serve as markers of the immune response. |
Note: | Versió postprint del document publicat a: https://doi.org/10.1136/gutjnl-2012-303006 |
It is part of: | Gut, 2013, vol. 62, num. 12, p. 1764-1770 |
URI: | http://hdl.handle.net/2445/126395 |
Related resource: | https://doi.org/10.1136/gutjnl-2012-303006 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
MichaudDS.pdf | 69.71 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.